5/15/2013 9:00:20 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
HASBROUCK HEIGHTS, N.J., May 15, 2013 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) announced today its financial results for the first quarter of 2013. Nymox reported a net loss of $1,093,906, or $0.03 per share for the quarter ended March 31, 2013, compared to $1,846,974, or $0.06 per share for the quarter ended March 31, 2012. The decrease in net losses in 2013 compared to 2012 is related to reductions in many areas of expenditures mainly due to a reduction in clinical trial expenditures as the NX-1207 studies near completion.
Help employers find you! Check out all the jobs and post your resume.
comments powered by